Clinical Trial Results:
Use of Palifermin to reduce the duration, frequency and severity of oral mucositis after high dose therapy with BEAM and autologous peripheral blood stem cell transplantation in patients with malign lymphoma, phase IV study
Summary
|
|
EudraCT number |
2008-001833-87 |
Trial protocol |
DE |
Global completion date |
30 Jun 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Sep 2020
|
First version publication date |
19 Sep 2020
|
Other versions |
|
Summary report(s) |
Abstract Talk Poster Doctoral disseration |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.